- Home
- DTST vs SCLX Comparison
DTST vs SCLX Comparison
Compare DTST & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- SCLX
- Stock Information
- Founded
- DTST 2001
- SCLX 2011
- Country
- DTST United States
- SCLX United States
- Employees
- DTST N/A
- SCLX N/A
- Industry
- DTST EDP Services
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- SCLX Health Care
- Exchange
- DTST Nasdaq
- SCLX Nasdaq
- Market Cap
- DTST 24.0M
- SCLX 28.4M
- IPO Year
- DTST N/A
- SCLX N/A
- Fundamental
- Price
- DTST $3.98
- SCLX $4.47
- Analyst Decision
- DTST
- SCLX Strong Buy
- Analyst Count
- DTST 0
- SCLX 4
- Target Price
- DTST N/A
- SCLX $396.67
- AVG Volume (30 Days)
- DTST 18.0K
- SCLX 208.7K
- Earning Date
- DTST 05-15-2025
- SCLX 05-23-2025
- Dividend Yield
- DTST N/A
- SCLX N/A
- EPS Growth
- DTST 40.00
- SCLX N/A
- EPS
- DTST 0.07
- SCLX N/A
- Revenue
- DTST $25,371,303.00
- SCLX $56,590,000.00
- Revenue This Year
- DTST $13.37
- SCLX $115.30
- Revenue Next Year
- DTST $8.51
- SCLX $73.33
- P/E Ratio
- DTST $58.14
- SCLX N/A
- Revenue Growth
- DTST 1.65
- SCLX 21.07
- 52 Week Low
- DTST $2.93
- SCLX $3.60
- 52 Week High
- DTST $8.00
- SCLX $80.50
- Technical
- Relative Strength Index (RSI)
- DTST 60.93
- SCLX 37.07
- Support Level
- DTST $3.45
- SCLX $3.92
- Resistance Level
- DTST $3.85
- SCLX $6.13
- Average True Range (ATR)
- DTST 0.18
- SCLX 0.71
- MACD
- DTST 0.05
- SCLX 0.12
- Stochastic Oscillator
- DTST 71.54
- SCLX 24.88
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.